Sign In   |   Register
Stresa - Current Perspective on the use of Statins in the treatment of Dyslipidemic Patients
Tell a Friend About This EventTell a Friend
 

27/06/2019
When: Thursday, June 27, 2019
Where: Grand Hotel Regina Palace
Corso Umberto I, 29
Stresa, Stresa VB  28838
Italy
Contact: Dr Marco Bordonaro
00393357773210

« Go to Upcoming Event List  

Cardiovascular disease account for ≈ 30% of mortality worldwide. The effective management of CV risk factor, such as dyslipidaemia, hypertension and insulin resistance is crucial for the reduction of CV related morbidity as well as mortality.

Among the CV factors for myocardial infarction, dyslipidaemia is the most significant risk factor, accounting for 50% of the population-attributable risk. However, despite the widespread availability of effective statins, the proportion of patients that fail to achieve their target according to national guidelines ranges from 16% to 53% worldwide. The aim of this meeting is to review the efficacy and safety of statins in the treatment of dyslipidaemia and examine their additional benefits beyond LDL-C reduction disease.

Any specialist in the area is entitle to attend. We expect more than 100 doctors participant coming from different European countries as well as Russia, China and Japan.

Final programme>>

Membership Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.